HEPATORENAL SYNDROME
- 1 May 2000
- journal article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 4 (2) , 487-507
- https://doi.org/10.1016/s1089-3261(05)70120-3
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeJournal of Hepatology, 1998
- Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortalityHepatology, 1998
- Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansionHepatology, 1998
- TIPS and refractory ascites. Lessons from the recent history of ascites therapyJournal of Hepatology, 1996
- Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failureJournal of Hepatology, 1993
- Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxideHepatology, 1992
- Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administrationJournal of Hepatology, 1990
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983
- The Hepatorenal SyndromeAnnals of Surgery, 1975
- ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES*Journal of Clinical Investigation, 1963